Overview

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of adapalene and benzoyl peroxide gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the treatment of Acne Vulgaris

Phase:

Phase 3

Details

Lead Sponsor:

Actavis Inc.

Treatments:

Adapalene
Adapalene, Benzoyl Peroxide Drug Combination
Benzoyl Peroxide